Jingyang Zhang
No.127, Dongming Road
Zhengzhou, 450000, China
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
C-type lectin domain family 5 member A-mediated activation of macrophages via a bispecific antibody enhances anti-HER2 therapy.
Journal: Journal for immunotherapy of cancer
Published: April 09, 2026
Global patterns and risk factors of breast cancer in women under 35: a population-based study.
Journal: Breast (Edinburgh, Scotland)
Published: June 21, 2025
Prognostic significance of HER2-low and HER2-zero status before and after neoadjuvant chemotherapy in patients with HER2-negative breast cancer.
Journal: Therapeutic advances in medical oncology
Published: May 05, 2025
Impact of Hormone Receptor Status and HER2 Expression on Neoadjuvant Targeted Therapy Response in HER2-Positive Breast Cancer: A Multicenter Retrospective Study.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 16, 2025
Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world study.
Journal: Breast (Edinburgh, Scotland)
Published: August 17, 2024
Breast reconstruction with combined greater omentum and prosthesis: A case report.
Journal: Asian journal of surgery
Published: January 13, 2023
Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy.
Journal: Cancer research and treatment
Published: December 29, 2022
ELOVL2-AS1 inhibits migration of triple negative breast cancer.
Journal: PeerJ
Published: January 06, 2022
Pyroptosis-Related Signatures for Predicting Prognosis in Breast Cancer.
Journal: Frontiers in surgery
Published: October 02, 2021
Analysis of the expression profile of serum exosomal lncRNA in breast cancer patients.
Journal: Annals of translational medicine
Published: June 16, 2021
Last Updated: 09/26/2026